Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma

NCT06918015 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

BTK Inhibitors
Follicular Lymphoma
Immunochemotherapy

Interventions

DRUG: ZGCVP

Sponsor

Zhejiang Cancer Hospital